Symetryx Corp - Sep 7, 2023 Form 4 Insider Report for NeuBase Therapeutics, Inc. (NBSE)

Role: 10%+ Owner
Signature: Barry Shiff
Stock symbol: NBSE
Transactions as of: Sep 7, 2023
Transactions value $: -$336,731
Form type: 4
Date filed: 9/11/2023, 06:08 PM
Previous filing: Sep 7, 2023
Next filing: Sep 18, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NBSE	Common Stock, Par Value $0.0001 per Share	Sale	-$135K	-74.9K	-11.01%	$1.80	605K	Sep 7, 2023	Direct	F1
transaction	NBSE	Common Stock, Par Value $0.0001 per Share	Sale	-$197K	-129K	-21.29%	$1.53	476K	Sep 8, 2023	Direct	F1
transaction	NBSE	Common Stock, Par Value $0.0001 per Share	Sale	-$4.86K	-3.38K	-0.71%	$1.44	473K	Sep 11, 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Of the 472,926 shares listed on Table I in Column 5 as beneficially owned by Symetryx Corporation prior to filing this Form 4: Symetryx Corporation beneficially owns 282,445 shares; Barry Shiff, an individual through his retirement accounts, beneficially owns 109,508 shares; and Aleta Shiff, an individual through her retirement accounts, beneficially owns 80,973 shares. As reported on the Schedule 13D dated August 30, 2023, these three shareholders may be deemed to beneficially own the shares of common stock beneficially owned by each other.

Content

Of the 472,926 shares listed on Table I in Column 5 as beneficially owned by Symetryx Corporation prior to filing this Form 4: Symetryx Corporation beneficially owns 282,445 shares; Barry Shiff, an individual through his retirement accounts, beneficially owns 109,508 shares; and Aleta Shiff, an individual through her retirement accounts, beneficially owns 80,973 shares. As reported on the Schedule 13D dated August 30, 2023, these three shareholders may be deemed to beneficially own the shares of common stock beneficially owned by each other.